≪Group photo of Speakers and Organizers≫
"The UTokyo NY Conference 2018" in New York"
"The UTokyo NY Conference 2018" hosted by the University of Tokyo New York office, Inc., and co-hosted by the Institute of Medical Science and Institute of Industrial Science,
was held at the Nippon Club Tower in New York on Saturday, November 3,
2018. Many people came from universities and research institutions in the
United States,
and companies and organizations in various fields to attend this conference.
The conference opened with opening remarks by Prof. Yoshinori
Murakami, Dean of IMSUT and Dr. Yuichiro Kuwama, Vice President of the UTokyo
NY office,
followed by the introduction of each institute by Dean Murakami
(IMSUT), and Deputy Director Katsuyuki Fukutani (IIS).
At the lecture, Project Professor Hiroshi Kiyono of IMSUT, talked about
the development and clinical application of the next generation oral vaccine
(MucoRice) using rice under the title "Rice became a vaccine".
Subsequently, Professor Yuji Yamanashi of IMSUT gave a lecture entitled
"Targeting neuromuscular synapses as a new therapeutic approach for
muscle weakness and atrophy".
This lecture was about the development of a new gene therapy for neuromuscular
diseases such as amyotrophic lateral sclerosis (ALS).
In the second part after the break, Professor Thomas Zwaka of Icahn School of Medicine at Mount Sinai gave a lecture entitled
"The unreasonable effectiveness of pluripotent stem cells: mechanism
and mechanics" highlighting the effectiveness of pluripotent stem
cells that has received much attention recently.
Next, Professor Miriam Merad of Icahn School of Medicine at Mount Sinai
gave a presentation titled "Harnessing the tumor microenvironment
to enhance cancer care"
to introduce the cutting edge data on cancer microenvironment and cancer
immunotherapy. Finally, Project Professor Tadatsugu Taniguchi of IIS,
spoke on "The role of dead cell-drived molecules in the progression
of inflammatory disease and cancer: implications for the development of
new therapeutic approaches.”
His talk focused on the development of new treatments for inflammatory
diseases and cancers.
Each lecture greatly stimulated the attendees, and the question and
answer time never seemed enough to satisfy the lively exchanges.
Finally, this successful conference was concluded with the closing
remarks by the Deputy Director of IIS, Prof. Fukutani.
Many attendees also participated in the reception following the conference, and exchanges were fostered that cross not only research discipline boundaries,
but national boundaries as well. Amid such meaningful exchanges, further utilization of the New York office is expected in the future.
≪Group photo of Speakers and
Organizers≫
≪Lecture by Prof. Yuji
Yamanashi of IMSUT ≫
≪Lecture by Prof. Miriam
Merad (Icahn School of Medicine at Mount Sinai)≫